Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007064080> ?p ?o ?g. }
- W2007064080 endingPage "2208" @default.
- W2007064080 startingPage "2201" @default.
- W2007064080 abstract "Objective To examine the effects of nebivolol, a β-blocker with nitroxide-mediated vasodilating properties, on coronary flow reserve (CFR) in patients with uncomplicated arterial hypertension. Design, setting and patients Fourteen newly diagnosed, never-treated, World Health Organization grade I–II hypertensive patients (male/female, 10/4; mean age, 47 years), free of coronary heart disease, underwent standard Doppler echocardiography and determination of CFR in the distal left anterior descending artery by low-dose dipyridamole (0.56 mg/kg intravenously in 4 min) at baseline and after 4 weeks of treatment with 5 mg nebivolol once daily. Results At baseline, nine patients had left ventricular (LV) hypertrophy (LV mass index ≥ 51 g/m2.7). After 4 weeks of therapy, the blood pressure was decreased from 148 ± 8.1/101.4 ± 4.6 mmHg to 140.7 ± 7.0/91.1 ± 7.4 mmHg and end-systolic stress was also significantly reduced. Heart rate was reduced (P < 0.01), whereas LV end-diastolic diameter and stroke volume tended to increase (P = 0.07 and P = 0.09, respectively). No changes were detected in the LV mass index, relative wall thickness, fractional shortening and LV diastolic properties. Both resting and dipyridamole rate–pressure products were lower after nebivolol but dipyridamole-induced changes were not influenced by the therapy. In contrast, nebivolol therapy did not alter coronary velocities at rest, but caused a greater increase in coronary velocities after dipyridamole (P < 0.03), leading to a greater CFR (2.12 ± 0.33 versus 1.89 ± 0.31, P < 0.0001). Nebivolol induced an absolute increase of 8% in the CFR in nine of 14 patients (64.3%). Conclusions In hypertensive patients free of coronary artery disease, 4-week nebivolol therapy induces a significant increase of the CFR. Nebivolol preserves coronary flow at rest despite the reduction of metabolic (O2 consumption) and hemodynamic (diastolic blood pressure) determinants. The increase of hyperemic coronary velocities appears due to the reduction of coronary resistance." @default.
- W2007064080 created "2016-06-24" @default.
- W2007064080 creator A5017007288 @default.
- W2007064080 creator A5019554234 @default.
- W2007064080 creator A5022677305 @default.
- W2007064080 creator A5066478061 @default.
- W2007064080 creator A5073163158 @default.
- W2007064080 date "2004-11-01" @default.
- W2007064080 modified "2023-10-16" @default.
- W2007064080 title "Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease" @default.
- W2007064080 cites W1571937066 @default.
- W2007064080 cites W1975465206 @default.
- W2007064080 cites W1976443287 @default.
- W2007064080 cites W1988224851 @default.
- W2007064080 cites W1993118035 @default.
- W2007064080 cites W1997017989 @default.
- W2007064080 cites W2007865489 @default.
- W2007064080 cites W2010194853 @default.
- W2007064080 cites W2011142053 @default.
- W2007064080 cites W2015795623 @default.
- W2007064080 cites W2017867909 @default.
- W2007064080 cites W2022239002 @default.
- W2007064080 cites W2023140063 @default.
- W2007064080 cites W2024380450 @default.
- W2007064080 cites W2024524546 @default.
- W2007064080 cites W2033120253 @default.
- W2007064080 cites W2036751971 @default.
- W2007064080 cites W2037604424 @default.
- W2007064080 cites W2037867131 @default.
- W2007064080 cites W2050061293 @default.
- W2007064080 cites W2057638108 @default.
- W2007064080 cites W2058044929 @default.
- W2007064080 cites W2064120846 @default.
- W2007064080 cites W2066724348 @default.
- W2007064080 cites W2067688224 @default.
- W2007064080 cites W2072073145 @default.
- W2007064080 cites W2077935074 @default.
- W2007064080 cites W2082191129 @default.
- W2007064080 cites W2083318967 @default.
- W2007064080 cites W2083752631 @default.
- W2007064080 cites W2085637395 @default.
- W2007064080 cites W2086832765 @default.
- W2007064080 cites W2088493953 @default.
- W2007064080 cites W2089711504 @default.
- W2007064080 cites W2128473845 @default.
- W2007064080 cites W2139330675 @default.
- W2007064080 cites W2141681173 @default.
- W2007064080 cites W2144016435 @default.
- W2007064080 cites W2155732513 @default.
- W2007064080 cites W2163628145 @default.
- W2007064080 cites W2166486120 @default.
- W2007064080 cites W2317496803 @default.
- W2007064080 doi "https://doi.org/10.1097/00004872-200411000-00024" @default.
- W2007064080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15480106" @default.
- W2007064080 hasPublicationYear "2004" @default.
- W2007064080 type Work @default.
- W2007064080 sameAs 2007064080 @default.
- W2007064080 citedByCount "53" @default.
- W2007064080 countsByYear W20070640802012 @default.
- W2007064080 countsByYear W20070640802013 @default.
- W2007064080 countsByYear W20070640802015 @default.
- W2007064080 countsByYear W20070640802019 @default.
- W2007064080 countsByYear W20070640802020 @default.
- W2007064080 countsByYear W20070640802021 @default.
- W2007064080 countsByYear W20070640802023 @default.
- W2007064080 crossrefType "journal-article" @default.
- W2007064080 hasAuthorship W2007064080A5017007288 @default.
- W2007064080 hasAuthorship W2007064080A5019554234 @default.
- W2007064080 hasAuthorship W2007064080A5022677305 @default.
- W2007064080 hasAuthorship W2007064080A5066478061 @default.
- W2007064080 hasAuthorship W2007064080A5073163158 @default.
- W2007064080 hasConcept C120770815 @default.
- W2007064080 hasConcept C126322002 @default.
- W2007064080 hasConcept C164705383 @default.
- W2007064080 hasConcept C2776002628 @default.
- W2007064080 hasConcept C2776890861 @default.
- W2007064080 hasConcept C2777537511 @default.
- W2007064080 hasConcept C2777953023 @default.
- W2007064080 hasConcept C2778213512 @default.
- W2007064080 hasConcept C2778707443 @default.
- W2007064080 hasConcept C2909076160 @default.
- W2007064080 hasConcept C57900726 @default.
- W2007064080 hasConcept C71924100 @default.
- W2007064080 hasConcept C84393581 @default.
- W2007064080 hasConceptScore W2007064080C120770815 @default.
- W2007064080 hasConceptScore W2007064080C126322002 @default.
- W2007064080 hasConceptScore W2007064080C164705383 @default.
- W2007064080 hasConceptScore W2007064080C2776002628 @default.
- W2007064080 hasConceptScore W2007064080C2776890861 @default.
- W2007064080 hasConceptScore W2007064080C2777537511 @default.
- W2007064080 hasConceptScore W2007064080C2777953023 @default.
- W2007064080 hasConceptScore W2007064080C2778213512 @default.
- W2007064080 hasConceptScore W2007064080C2778707443 @default.
- W2007064080 hasConceptScore W2007064080C2909076160 @default.
- W2007064080 hasConceptScore W2007064080C57900726 @default.
- W2007064080 hasConceptScore W2007064080C71924100 @default.
- W2007064080 hasConceptScore W2007064080C84393581 @default.
- W2007064080 hasIssue "11" @default.